
Lornizid P 8mg/325mg Tablet
Marketer
Spancer Pharmaceuticals
Salt Composition
Lornoxicam (8mg) + Paracetamol (325mg)
Overview Lornizid P 8mg/325mg Tablet
Lorinza 8mg/325mg tablets offer relief from pain and inflammation. This medication is indicated for conditions such as rheumatoid arthritis, ankylosing spondylitis, and osteoarthritis, as well as for muscle aches, back pain, dental pain, and ear, nose, and throat discomfort. Optimal absorption occurs on an empty stomach; dosage is determined by the specific condition and individual response, always following your physician's instructions. Never exceed the prescribed dose or duration. Common adverse reactions may include nausea, vomiting, dyspepsia, abdominal pain, and diarrhea. Report any persistent or worsening side effects to your doctor, who can offer strategies for mitigation. Prior to commencing treatment, inform your doctor of any pre-existing stomach ulcers or bleeding, hypertension, or cardiovascular, renal, or hepatic dysfunction. Complete disclosure of all other medications is crucial due to potential interactions. Consult your physician before using this medication if you are pregnant, breastfeeding, or plan to consume alcohol, as alcohol can heighten drowsiness.
Uses of Lornizid P 8mg/325mg Tablet
Analgesia
Major Benefits of Lornizid P 8mg/325mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for Lornizid P 8mg/325mg Tablets. Swallow each tablet whole; do not crush, chew, or break it. Administer on an empty stomach.
Common Side effects of Lornizid P 8mg/325mg Tablet:
- Nausea
- Vomiting
- Indigestion
- Stomach pain
- Diarrhea
How to use Lornizid P 8mg/325mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Lornizid P 8mg/325mg tablet whole; avoid chewing, crushing, or breaking it. Administer on an empty stomach.
How Lornizid P 8mg/325mg Tablet works:
Each Lornizid P 8mg/325mg tablet combines lornoxicam and paracetamol to alleviate pain. This dual action medication inhibits the production of chemicals responsible for pain signals and inflammatory responses, such as swelling and redness.
SAFETY ADVICE
AlcoholUNSAFE
Combining Lornizid P 8mg/325mg tablets with alcohol is inadvisable due to safety concerns.
PregnancyCONSULT YOUR DOCTOR
Data on Lornizid P 8mg/325mg Tablet use in pregnancy is lacking. Seek medical advice from your physician.
Breast feedingCONSULT YOUR DOCTOR
Data on the compatibility of Lornizid P 8mg/325mg tablets with breastfeeding are lacking. Seek medical advice from your physician.
DrivingCONSULT YOUR DOCTOR
Driving ability while taking Lornizid P 8mg/325mg Tablet is undetermined. Refrain from driving if experiencing symptoms impairing concentration or reaction time.
KidneySAFE IF PRESCRIBED
Lornizid P 8mg/325mg tablets pose no safety concerns for patients with renal impairment; no dosage modification is necessary.
LiverCONSULT YOUR DOCTOR
Insufficient data exists regarding the use of Lornizid P 8mg/325mg tablets in individuals with hepatic impairment. Physician consultation is advised.
What if you forget to take Lornizid P 8mg/325mg Tablet :
Should you forget a Lornizid P 8mg/325mg Tablet, take it immediately. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing pattern. Avoid taking a double dose.
Facts to Know About Lornizid P 8mg/325mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Pain Relief Medications |
